Drug application
HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX (CHLORPHENIRAMINE POLISTIREX, HYDROCODONE POLISTIREX)
Drugs@FDA ANDA 091632 · TRIS PHARMA INC
Key facts
| Drug name | HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX |
|---|---|
| Active ingredients | CHLORPHENIRAMINE POLISTIREX, HYDROCODONE POLISTIREX |
| Application type | ANDA |
| Application number | 091632 |
| Company | TRIS PHARMA INC |
| Dosage forms | SUSPENSION, EXTENDED RELEASE, ORAL |
| Strength | EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission class | Not Applicable |
| Latest submission status date | Oct 1, 2010 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- No FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: